You are here: Industry Insights > NTAGI

News List

Experts considering scientific evidence on need for booster dose against COVID expresspharma
December 01, 2021
The National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence for the need and justification for booster dose, Rajya Sabha...
ICMR study finds pregnant, postpartum women more severely affected during COVID second wave expresspharma
June 18, 2021
Symptomatic cases were significantly higher at 28.7 per cent in the second wave, compared to the first wave when the proportion was 14.2 per cent, ICMR said.
Government to set up national platform to track and verify impact of COVID-19 vaccines expresspharma
May 17, 2021
The current data harmonisation work of ICMR and other agencies can be leveraged to set up this facility for review of ground realities on real-time basis, recommended NTAGI.
NTAGI recommends gap of 12-16 weeks between doses of Covishield expresspharma
May 14, 2021
It has also suggested that pregnant women may be offered the choice to take any COVID-19 vaccine and that lactating women can be inoculated any time after delivery.
Interval between two doses of COVISHIELD increased to 4-8 weeks expresspharma
March 23, 2021
Protection enhanced if the second dose of COVISHIELD is administered between 6-8 weeks, says NTAGI and NEGVAC.